|
Oct 7
|
Starboard Value takes $1 billion stake in Pfizer: Reports
|
|
Oct 4
|
BioNTech's (NASDAQ:BNTX) investors will be pleased with their massive 749% return over the last five years
|
|
Oct 1
|
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
|
|
Oct 1
|
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
|
|
Sep 25
|
As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech
|
|
Sep 25
|
Covid-19 vaccine patent legal battle heading to Court of Appeal
|
|
Sep 23
|
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
|
|
Aug 23
|
The FDA Approved New Covid Vaccines. Should You Get One?
|
|
Aug 23
|
FDA Approves Pfizer & Moderna's Updated COVID-19 Jabs
|
|
Mar 21
|
BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript
|
|
Mar 21
|
Q4 2023 BioNTech SE Earnings Call
|
|
Mar 20
|
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
|
|
Mar 20
|
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
|
|
Mar 20
|
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
|
|
Mar 20
|
BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline
|
|
Mar 20
|
BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.
|
|
Mar 20
|
UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches
|
|
Mar 20
|
BioNTech slides as earnings plunge amid cancer drug shift
|
|
Mar 20
|
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
|
|
Mar 20
|
After earnings plunge, BioNTech pins hopes on cancer drug launches
|